REG - British Amer.Tobacco - Publication of Suppl.Prospcts

British American TobaccoAnnouncement

28/03/2024 10:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240328:nRSb6945Ia&default-theme=true

RNS Number : 6945I  British American Tobacco PLC  28 March 2024

Publication of Supplementary Prospectus

The following Supplementary Prospectus has been approved by the Financial
Conduct Authority and is available for viewing:

Supplementary Prospectus dated 28 March 2024 (the "Supplementary Prospectus")
relating to the £25,000,000,000 Euro Medium Term Note Programme of B.A.T.
International Finance p.l.c., B.A.T Capital Corporation and B.A.T. Netherlands
Finance B.V. (as Issuers) and British American Tobacco p.l.c. and each of the
Issuers (except where it is the relevant Issuer) (as Guarantors).

The Supplementary Prospectus should be read and construed in conjunction with
the Base Prospectus dated 5 March 2024 (the "Prospectus").

To view the Supplementary Prospectus, please paste the following URL into the
address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/6945I_1-2024-3-28.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/6945I_1-2024-3-28.pdf)

The full document will be submitted to the National Storage Mechanism and will
shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

Enquiries

British American Tobacco Press Office

+44 (0)20 7845 2888 (24 hours) │@BATPlc

British American Tobacco Investor Relations

Victoria Buxton / Amy Chamberlain / Yetunde Ibe / John Harney / Jane Henderson

+44 (0)20 7845 2012 / 1124 / 1095 / 1263 / 1117

British American Tobacco p.l.c.

Globe House

4 Temple Place

London WC2R 2PG

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed
to and/or targeted at persons who are residents of particular countries
(specified in the Prospectus) only and is not intended for use and should not
be relied upon by any person outside these countries and/or to whom the offer
contained in the Prospectus is not addressed. Prior to relying on the
information contained in the Prospectus, you must ascertain from the
Prospectus whether or not you are one of the intended addressees of the
information contained therein.

Your right to access this service is conditional upon complying with the above
requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PSPEANDPALNLEEA